Skip to main content
SpringerLink
Log in

The Effects of Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients with Mild Obesity (BMI 30–35 kg/m2) and Simple Overweight (BMI 25–30 kg/m2): A Prospective Controlled Study

  • Clinical Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Beneficial effects of BPD on T2DM in BMI >35 kg/m2 patients are far better than those in patients with BMI 25–35. This study was aimed at investigating if a similar difference exists between patients with mild obesity (OB, BMI 30–35) or simple overweight (OW, BMI 25–30).

Methods

Fifteen OB (six M) and 15 OW (13 M), diabetic for ≥3 years, with HbA1c ≥7.5% despite medical therapy, underwent BPD. OB/OW: age 55.1 ± 8.0/57.8 ± 6.7 years, BMI 33.1 ± 1.5/28.0 ± 1.3 kg/m2, diabetes duration 11.6 ± 8.0/11.1 ± 6.1 years, insulin therapy 4/8 p. FSG and HbA1c were determined preoperatively and up to 2 years. Insulin resistance and beta-cell function were explored by means of HOMA-IR and IVGTT (AIR). Thirty-eight diabetic patients on medical therapy served as controls.

Results

Mean BMI stabilized around 27 since the 4th month in OB, and 24 since 1st month in OW. FSG in OB/OW preop, 1, 12, 24 months: 234 ± 76/206 ± 62 mg/dL, 154 ± 49/176 ± 75, 131 ± 32/167 ± 48, 134 ± 41/154 ± 41 (cross-sectional n.s. at all times); HbA1c: 9.5 ± 1.6/9.1 ± 1.3, 7.3 ± 1.1/7.3 ± 1.2, 5.9 ± 0.6/7.1 ± 1.1 (p < 0.01), 5.9 ± 0.9/6.9 ± 1.1 (p < 0.01). HOMA-IR, preoperatively 10.7 ± 5.8/7.5 ± 5.4, went below 3.0 at 1 month and remained such until 2 years in both groups. AIR, preoperatively 1.11 ± 3.17/1.27 ± 2.68 μIU/mL, in OB significantly increased at 4 months to 7.63 ± 5.79, maintained up to 2 years with 6.95 ± 3.19, whereas in OW, statistical significance was reached only at 2 years with 5.02 ± 4.87.

Conclusions

Significantly different BPD effect, thus biological severity of T2DM, also exists between mildly obese and simply overweight patients. The rise of AIR allows hoping that an increase of beta-cell mass may occur in the long run.

ClinicalTrials.gov Identifier: NCT00996294

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic Bypass for Obesity: II. Initial Experience in Man. Br J Surg. 1979;66:618–20.

    Article  PubMed  CAS  Google Scholar 

  2. Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic Diversion for Obesity at Eighteen Years. Surgery. 1996;119:261–8.

    Article  PubMed  CAS  Google Scholar 

  3. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic Diversion. World J Surg. 1998;22:936–46.

    Article  PubMed  CAS  Google Scholar 

  4. Scopinaro N, Gianetta E, Friedman D, et al. Evolution of Biliopancreatic Bypass. Clin Nutr. 1986;5(suppl):137–46.

    Google Scholar 

  5. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a Systematic Review and Meta-analysis. JAMA. 2004;292:1724–37.

    Article  PubMed  CAS  Google Scholar 

  6. Buchwald H, Estok R, Fahrbach K, et al. Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis. Am J Med. 2009;122:248–56.

    Article  PubMed  Google Scholar 

  7. Scopinaro N, Marinari GM, Camerini GB, et al. Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome: A Long-term Follow-up Study. Diabetes Care. 2005;28:2406–11.

    Article  PubMed  Google Scholar 

  8. Scopinaro N, Papadia F, Camerini G, et al. A Comparison of a Personal Series of Biliopancreatic Diversion and Literature Data on Gastric Bypass Help to Explain the Mechanisms of Resolution of Type 2 Diabetes by the Two Operations. Obes Surg. 2008;18:1035–8.

    Article  PubMed  Google Scholar 

  9. McAuley K, Mann J. Thematic Review Series: Patient Oriented Research. Nutritional Determinants of Insulin Resistance. J Lipid Res. 2006;47:1668–76.

    Article  PubMed  CAS  Google Scholar 

  10. Brandi LS, Santoro D, Natali A, et al. Insulin Resistance of Stress: Sites and Mechanisms. Clin Sci (Lond). 1993;85:525–35.

    CAS  Google Scholar 

  11. Thorell A, Nygren J, Ljungqvist O. Insulin Resistance: A Marker of Surgical Stress. Curr Opin Clin Nutr Metab Care. 1999;2:69–78.

    Article  PubMed  CAS  Google Scholar 

  12. Adami GF, Cordera R, Camerini G, et al. Recovery of Insulin Sensitivity in Obese Patients at Short Term after Biliopancreatic Diversion. J Surg Res. 2003;113:217–21.

    Article  PubMed  CAS  Google Scholar 

  13. Wickremesekera K, Miller G, Naotunne TD, et al. Loss of Insulin Resistance after Roux-en-Y Gastric Bypass Surgery: A Time Course Study. Obes Surg. 2005;15:474–81.

    Article  PubMed  Google Scholar 

  14. Briatore L, Salani B, Andraghetti G, et al. Restoration of Acute Insulin Response in T2DM Subjects 1 Month after Biliopancreatic Diversion. Obesity. 2008;16:77–81.

    Article  PubMed  Google Scholar 

  15. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, et al. Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects with Type 2 Diabetes Following Bariatric Surgery. Diabetes. 2003;52:1098–103.

    Article  PubMed  CAS  Google Scholar 

  16. Adami GF, Murelli F, Briatore L, et al. Pregnancy in Formerly Type 2 Diabetes Obese Women Following Biliopancreatic Diversion for Obesity. Obes Surg. 2008;18:1109–11.

    Article  PubMed  Google Scholar 

  17. Doyle ME, Egan JM. Mechanisms of Action of Glucagone-like Peptide 1 in the Pancreas. Pharmacol Ther. 2007;113:546–93.

    Article  PubMed  CAS  Google Scholar 

  18. Xu G, Stoffers DA, Habener JF, et al. Exendin-4 Stimulates Both Beta-cell Replication and Neogenesis, Resulting in Increased Beta-cell Mass. Diabetes. 1999;48:2270–6.

    Article  PubMed  CAS  Google Scholar 

  19. Farilla L, Bulotta A, Hirshberg B, et al. Glucagon-like Peptide 1 Inhibits Cell Apoptosis and Improve Glucose Responsiveness of Freshly Isolated Human Islets. Endocrinology. 2003;144:5149–58.

    Article  PubMed  CAS  Google Scholar 

  20. Borg CM, le Roux CW, Ghatei MA, et al. Biliopancreatic Diversion in Rats is Associated with Intestinal Hypertrophy and with Increased GLP-1, GLP-2 and PYY levels. Obes Surg. 2007;17:1193–8.

    Article  PubMed  Google Scholar 

  21. Valverde I, Puente J, Martín-Duce A, et al. Changes in Glucagon-like Peptide-1 (GLP-1) Secretion after Biliopancreatic Diversion or Vertical Banded Gastroplasty in Obese Subjects. Obes Surg. 2005;15:387–97.

    Article  PubMed  Google Scholar 

  22. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of Recovery from Type 2 Diabetes after Malabsorptive Bariatric Surgery. Diabetes. 2006;55:2025–31.

    Article  PubMed  CAS  Google Scholar 

  23. Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopancreatic diversion on type 2 diabetes in patients with BMI 25–35. Ann Surg. 2011;253:699–703.

    Article  PubMed  Google Scholar 

  24. Scopinaro N, Marinari GM, Camerini G, et al. Energy and Nitrogen Absorption after Biliopancreatic Diversion. Obes Surg. 2000;10:436–41.

    Article  PubMed  CAS  Google Scholar 

  25. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34.

    Google Scholar 

  26. Beil U, Crouse JR, Einarsson K, et al. Effects of Interruption of the Enterohepatic Circulation of Bile Acids on the Transport of Very Low Density-lipoprotein Triglycerides. Metabolism. 1982;31:438–44.

    Article  PubMed  CAS  Google Scholar 

  27. Ast M, Frishman WH. Bile Acid Sequestrants. J Clin Pharmacol. 1990;30:99–106.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Genoa Medical School, Genoa, Italy

    Nicola Scopinaro, Giovanni F. Adami, Francesco S. Papadia, Giovanni Camerini, Flavia Carlini, Gabriele D’Alessandro, Corrado Parodi, Andrea Weiss & Mariafrancesca Catalano

  2. Department of Endocrinology, University of Genoa Medical School, Genoa, Italy

    Lucia Briatore, Gabriella Andraghetti & Renzo Cordera

  3. DISC, Università di Genova, Azienda Ospedaliera Universitaria “San Martino”, Largo Rosanna Benzi, 8, 16132, Genoa, Italy

    Nicola Scopinaro

Authors
  1. Nicola Scopinaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni F. Adami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco S. Papadia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni Camerini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Flavia Carlini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lucia Briatore
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gabriele D’Alessandro
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Corrado Parodi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Andrea Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gabriella Andraghetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Mariafrancesca Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Renzo Cordera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicola Scopinaro.

Additional information

ClinicalTrials.gov Identifier

NCT00996294

None of the authors has any commercial interest in the subject of the study and the source of any financial or material support.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scopinaro, N., Adami, G.F., Papadia, F.S. et al. The Effects of Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients with Mild Obesity (BMI 30–35 kg/m2) and Simple Overweight (BMI 25–30 kg/m2): A Prospective Controlled Study. OBES SURG 21, 880–888 (2011). https://doi.org/10.1007/s11695-011-0407-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-011-0407-0

Keywords

Search

Navigation